Document Detail

Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes.
MedLine Citation:
PMID:  19676148     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Conventional cardiac markers used for the biochemical diagnosis of acute coronary syndromes (ACS) have a high specificity but low sensitivity within 2-4 h of symptoms onset. The red blood cell distribution width (RDW), reflecting the size variability of circulating red blood cells, has been shown to be independently associated with an increased risk of major cardiovascular events. We assessed whether there is an association between RDW at admission and cardiac troponin T (cTnT) elevation in patients with chest pain. METHODS: We analyzed RDW values in 2304 adult patients, who were consecutively admitted over a 1-year period to the local emergency department for chest pain suggestive of ACS. In all patients, a baseline blood sample was collected for routine haematological testing, whereas cTnT was measured at baseline and after 4, 6, and 12 h. RESULTS: A total of 456 patients (19.8% of total) had ACS. These patients, all having cTnT> or =0.03 microg/L up to 12 h from admission other than ischaemic electrocardiographic changes, had higher RDW than non-ACS patients [median 15.1%, (5th-95th percentiles) 13.2%-19.0% vs. 13.5%, 12.9%-17.1%, p<0.001]. On admission, the sensitivity and specificity of cTnT were 94% (25 false negative results) and 100%, respectively. The diagnostic accuracy of RDW, as calculated by the receiver operating characteristic curve analysis, was 0.705 (p<0.001). At the cut-off value of 14%, the clinical sensitivity and specificity of RDW on admission were 79% and 50%, respectively. In 21 out of 25 patients classified as false negative for cTnT on admission, the RDW was >14%. Accordingly, the diagnostic sensitivity of the two combined measurements on admission was 99%. CONCLUSIONS: As RDW is widely available to clinicians as a part of the complete blood count, and therefore incurs no additional costs, it might be considered with other conventional cardiac markers for the risk stratification of ACS patients admitted to emergency departments.
Giuseppe Lippi; Luca Filippozzi; Martina Montagnana; Gian Luca Salvagno; Massimo Franchini; Gian Cesare Guidi; Giovanni Targher
Related Documents :
14652168 - Risk factors for lipodystrophy in the cisai cohort.
25342098 - Clinical characteristics and sap scintigraphic findings in 10 patients with agel amyloi...
14645888 - Organizing patient safety research to identify risks and hazards.
9296468 - Key factors in the identification of the high-risk patient with unstable coronary arter...
23047848 - Mri and neurological findings in patients with spinal metastases.
23972508 - Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical chemistry and laboratory medicine : CCLM / FESCC     Volume:  47     ISSN:  1434-6621     ISO Abbreviation:  Clin. Chem. Lab. Med.     Publication Date:  2009  
Date Detail:
Created Date:  2009-08-13     Completed Date:  2009-08-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9806306     Medline TA:  Clin Chem Lab Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  353-7     Citation Subset:  IM    
Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / blood*,  diagnosis
Aged, 80 and over
Biological Markers / blood
Erythrocyte Indices*
Middle Aged
ROC Curve
Sensitivity and Specificity
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronar...
Next Document:  Evaluation of the BD Vacutainer PST II blood collection tube for special chemistry analytes.